Our collaboration partner Nexel is offering iPSC-derived cells for Assays on Nanion's Instruments
NEXEL is progressing with a sense of mission to make a better world through the commercialization of stem cell research. With NEXEL’s cutting-edge technologies, NEXEL manufactures human cell products derived from iPS Cell to develop more efficient tools for new drug discovery / development, and various innovative applications.
The following cells were validated on Nanion's Instruments:
NEXEL’s Cardiosight-S® provides a highly pure (≥95%) and mature population of cardiomyocytes differentiated from human induced pluripotent stem cells (hiPSC) with validated human cardiac characteristics and functions. These cardiomyocytes accurately and reproducibly predict human cardiac toxicity in vitro, proving a useful tool for safety pharmacology testing and drug screening. They also support various research platforms such as 3D bioprinting, lab-on-a-chip, and organoid.
Collaborative Activities with Nexel